MHRA showcases next phase of regulatory science

Digital pathology firm Diagnexia and Stratipath AB, a pioneer in AI-based cancer diagnostics, have announced a strategic partnership to bring Stratipath Breast, an AI-based prognostic risk profiling tool for invasive breast cancer, to pathology...

The Association for Molecular Pathology and pathologist Michael Laposata MD PhD, have announced a favourable ruling in their lawsuit against the U.S. Food and Drug Administration over the regulation of laboratory-developed test (LDT) procedures.

The National Cancer Institute (NCI), part of the U.S. National Institutes of Health (NIH), is to partner with cancer diagnostics firm Lunit to explore innovative applications of AI in cancer research.

Richard Hames, General Manager of Werfen UK, has been elected Chair of the British In Vitro Diagnostics Association (BIVDA).